 Since 2013, Jean Stéphenne is shareholder and chairman of OncoDNA.Since September 2015 he was a membre of the supervisory board of CureVac, a german biopharmaceutical company specialising in mRNA-based drugs.In April 2020, he was appointed as the Chairman of the company.